or
forgot password

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer


N/A
18 Years
70 Years
Not Enrolling
Female
Breast Cancer, Early Stage Breast Cancer (Stage 1-3)

Thank you

Trial Information

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer


Inclusion Criteria:

- Stage I or II breast cancer

- Post-op

- On treatment protocol of eight weeks of AC given every other week followed by 8 weeks
of paclitaxel given every other week

- ECOG Performance Status: 0-2

- Speak and read English

Exclusion Criteria:- Previous chemotherapy exposure

- Concomitant energy work interventions (HT, Reiki, QiGong, acupuncture).

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

FACT-B summary score

Outcome Time Frame:

Baseline, 6 wks, 14 wks

Safety Issue:

No

Principal Investigator

Dr. Ellie Guardino MD/PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

BRSADJ0007

NCT ID:

NCT00533663

Start Date:

April 2007

Completion Date:

August 2010

Related Keywords:

  • Breast Cancer
  • Early Stage Breast Cancer (Stage 1-3)
  • Breast Neoplasms

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317